Circulation · 2010 · 190 citations · 38 references
Inhibitors of ERK and JNK signaling could potentially be used to treat humans with cardiomyopathy caused by LMNA mutations.
38
Kim Fox · The Lancet · 2003 · 2.1K citations
Coronary Heart Disease, Health Policy, Cardiovascular Disease +9